Survival outcomes following colorectal cancer surgery in low- and middle-income countries: A systematic review.

Authors

null

Tom M. Diehl

University of Wisconsin Hospitals and Clinics, Madison, WI

Tom M. Diehl , Adel H. Khan , Nabiha Akhlaq Mughal , Daniel T. Schroeder , Sheida Pourdashti , Leslie Christensen , Sadaf Khan , Syed Nabeel Zafar

Organizations

University of Wisconsin Hospitals and Clinics, Madison, WI, Khyber Medical College, Peshawar, Pakistan, The Aga Khan University, Karachi City, Pakistan, University of Wisconsin School of Medicine and Public Health, Madison, WI, Aga Khan University, Karachi, Pakistan, Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison, Madison, WI

Research Funding

U.S. National Institutes of Health
Fogarty International Center

Background: Colorectal cancer (CRC) is a surgical disease that ranks among leading causes of global deaths, but little is known about survival outcomes following CRC surgery in low- and middle-income countries (LMICs). In this study, we sought to review all published literature on long-term outcomes following CRC resections in LMICs. Methods: We completed a systematic review of original research articles presenting survival outcomes after CRC resection with curative intent in LMICs. Databases searched included PubMed, Web of Science, Embase, and Global Index Medicus. Country income groupings were determined by 2020 World Bank data. We excluded articles involving pediatric populations (<18 years), non-primary colorectal cancers, benign disease, and endoscopic/transanal resection only. Articles published before 2005 or without English full text were also excluded. Abstracts and full texts were assessed for eligibility by two independent reviewers; conflicts were resolved by a third reviewer. Data from China dominated the published literature and were excluded from final analysis. Survival data were extracted for 5-year disease free survival (DFS) and overall survival (OS). Results: Our search returned 29,134 articles. After automated and manual deduplication, 18,849 abstracts were assessed for eligibility. Following abstract and full-text review, 583 articles met the inclusion criteria for the study. Table 1 shows the most-represented countries and their associated income levels. In total, 1/27 low-income countries, 11/55 lower-middle income countries, and 16/55 upper-middle income countries were represented, which accounted for 0.3%, 12.9% and 86.8% of all included articles, respectively. The majority of articles were from China (379/583; 65%). Excluding data from China, 5-year disease DFS and OS varied significantly across included studies: Stage I = 64-100% DFS and 70-100% OS; Stage II = 75-94% DFS and 50-94% OS; Stage III = 34-87% DFS and 20-93% OS; Stages I-III combined = 53-86% DFS and 29-97% OS. Conclusions: There is a dearth of data on long-term outcomes following CRC operations in LMICs, especially among low-income countries. OS ranges markedly by country income group highlighting global disparities in cancer care. Our review emphasizes a dire need for cancer research capacity building in LMICs.

Included article count by country.

Country
Article Countn (%)
World Bank Income Group
Country (cont.)
Article Countn (%)
World Bank Income Group
China
379 (65.0)
UM
Romania
7 (1.2)
UM
Turkey
55 (9.4)
UM
Malaysia
5 (0.9)
UM
Brazil
25 (4.3)
UM
Serbia
5 (0.9)
UM
India
22 (3.8)
LM
Sri Lanka
4 (0.7)
LM
Egypt
17 (2.9)
LM
Morocco
3 (0.5)
LM
Iran
14 (2.4)
LM
Argentina
2 (0.3)
UM
Thailand
10 (1.7)
UM
Bulgaria
2 (0.3)
UM
Mexico
8 (1.4)
UM
Ethiopia
2 (0.3)
L
Pakistan
7 (1.2)
LM
Jamaica
2 (0.3)
UM

*Low income (L), Lower middle income (LM), Upper middle income (UM).

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3544)

DOI

10.1200/JCO.2022.40.16_suppl.3544

Abstract #

3544

Poster Bd #

338

Abstract Disclosures